Brazilian consensus on gastroesophageal reflux disease: Proposals for assessment, classification, and management

American Journal of Gastroenterology

Volumn 97, Issue 2, 2002, Pages 241-248

  Moraes Filho, Joaquim Prado P ^a,e   Cecconello, Ivan ^a,b,c,d   Gama Rodrigues, Joaquim ^a,b,c,d   De Paula Castro, Luiz ^a,b,c,d   Henry, Maria Aparecida ^a,b,c,d   Meneghelli, Ulisses G ^a,b,c,d   Quigley, Eamonn ^a,b,c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; BEHAVIOR MODIFICATION; BRAZIL; CLINICAL FEATURE; ENDOSCOPY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PRESSURE; ESOPHAGUS STENOSIS; GASTROESOPHAGEAL REFLUX; HUMAN; MANOMETRY; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; ULCER;

EID: 0036180921     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04038-2     Document Type: Article

References (60)

1. An evidence based appraisal of reflux disease management. The Genval workshop report
2. Consensus statement for management of gastroesophageal reflux disease. Result of workshop meeting at Yale University School of Medicine, Department of Surgery, November 16 and 17, 1997
3. The second Canadian gastroesophageal reflux disease consensus: Moving forward to new concepts
4. Reflux gastroesophagien de l'adulte - Diagnostic et traitment
5. The screening sensitivity of endoscopy, acid perfusion test and 24-hour pH-monitoring to evaluate esophagitis in patients with heartburn and histological esophagitis
6. Symptomatic gastroesophageal reflux: Incidence and precipiting factors
7. Prevalence and clinical spectrum of gastroesophageal reflux: A population based study in Olmsted County, Minnesota
8. Heartburn and globus in apparently healthy people
9. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population
10. The prevalence of symptoms suggestive of esophageal disorders
11. Dyspepsia in England and Scotland
12. Gastroesophageal reflux disease
13. Symptoms in gastroesophageal reflux disease
14. How to diagnose and treat gastroesophageal reflux disease
15. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
16. Treatment of gastroesophageal reflux disease: Use of algorithms to aid in management
17. A tailored approach to antireflux surgery
18. Chest pain and gastroesophageal reflux disease
19. Oral and pharyngeal complications of gastroesophageal reflux disease: Globus, dental erosions, chronic sinusitis
20. Gastroesophageal reflux disease and asthma
21. Laryngeal complications of GERD
22. Gastroesophageal reflux disease and Barrett's esophagus
23. Diseases of the esophagus
24. Survival following surgical treatment of gastric cancer
25. Gastric cancer: A curable disease in Britain
26. The esophagus
27. Applications of radionuclide imaging in gastroenterology
28. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment. Suggested disease management guidelines
29. Gastro-oesophageal reflux disease in primary care. Comparison and evaluation of existing national guidelines and development of uniform European guidelines
30. Technique, indications, and clinical use of 24 hours esophageal pH monitoring
31. Clinical esophageal pH recording: A technical review for practice guideline development
32. Management of gastroesophageal reflux disease 1995. Pathophysiological basis of therapy for gastroesophageal reflux disease
33. Reflux rising - A burning issue! A personal overview of treatment
34. Why is the high-grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective
35. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome
36. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
37. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
38. Management of post-fundoplication complications
39. Gastroesophageal reflux disease: Surgical options, choice of operations and outcomes
40. Laparoscopic Nissen fundoplication: Cost, morbidity and outcome compared with open surgery
41. Initial medical versus surgical therapy for complicated chronic gastroesophageal reflux disease: A cost effectiveness analysis
42. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients
43. Laparoscopic antireflux surgery
44. Gastroesophageal reflux: Conventional surgical treatment versus laparoscopy. A prospective study of 61 cases
45. Quality of life assessment after laparoscopic and open fundoplication
46. Comparison of outcome of open versus laparoscopic Nissen fundoplication performed in a single practice
47. Effect of segment length on risk for neoplasic progression in patinets with Barrett esophagus
48. Barrett's esophagus. A prevalent occult complication of gastroesophageal reflux disease
49. Epidemiology of columnar lined esophagus and adenocarcinoma
50. Short Barrett: Prevalence and risk factors
51. Columnar mucosa and intestinal metaplasia of the esophagus: Fifty years of controversy
52. Endoscopic surveillance of Barrett's esophagus, risk stratification and cancer risk
53. Surgery for high-grade dysplasia in Barrett's esophagus
54. Barrett's esophagus. Long term management objectives
55. Recurrent peptic strictures: Management options
56. Esophageal function in patients with reflux-induced strictures and its relevance to surgical treatment